Efficacy and Tolerability of Intravenous Ferric Carboxymaltose in Patients with Iron Deficiency at a Hospital Outpatient Clinic: A Retrospective Cohort Study of Real-World Clinical Practice

Table 2

Hematological laboratory tests before and after treatment with intravenous ferric carboxymaltose (FCM).

Variables	Before treatment	After treatment	value
Hemoglobin (g/dL)	10.67 (1.67)	12.65 (1.26)	<0.001
Hematocrit (%)	33.32 (4.48)	38.57 (3.81)	<0.001
MCV (fL)	80.67 (8.94)	86.75 (6.56)	<0.001
MCH (pg)	25.62 (3.63)	28.30 (2.37)	<0.001
Ferritin (μg/dL)	9.60 (5.70–24.00)	137.00 (59.95–243.10)	<0.001
Transferrin saturation (%)	8.70 (4.76)	25.02 (10.16)	<0.001

Values are expressed as mean (standard deviation) or median (1st quartile-3rd quartile). Laboratory reference ranges in normal adults: hemoglobin, 12.0–15.3 g/dL (female) and 13.0–17.5 g/dL (male); hematocrit, 36–46% (female) and 40–50% (male); MCV, 80–97 fL; MCH, 27–33 pg; ferritin, 13–150 μg/dL (female) and 30–400 μg/dL (male); MCH: mean corpuscular hemoglobin; MCV: mean corpuscular volume.